HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 148 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,533,000 | -96.2% | 40,000 | -97.2% | 0.08% | -95.6% |
| Q2 2021 | $40,170,000 | -63.6% | 1,422,953 | -57.4% | 1.78% | -60.9% |
| Q1 2021 | $110,234,000 | -15.8% | 3,336,378 | -7.9% | 4.55% | -18.9% |
| Q4 2020 | $130,952,000 | +2.9% | 3,622,471 | -3.5% | 5.61% | -11.2% |
| Q3 2020 | $127,294,000 | – | 3,754,973 | – | 6.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $496,847,000 | 95.45% |
| Vivo Capital, LLC | 3,400,261 | $150,598,000 | 16.63% |
| Nan Fung Group Holdings Ltd | 510,978 | $22,631,000 | 14.44% |
| venBio Partners LLC | 1,125,673 | $49,856,000 | 11.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $11,715,000 | 3.76% |
| ASHFORD CAPITAL MANAGEMENT INC | 490,768 | $21,736,000 | 3.32% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 636,485 | $28,190,000 | 2.79% |
| Octagon Capital Advisors LP | 243,500 | $10,785,000 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 310,000 | $13,730,000 | 1.68% |
| Lisanti Capital Growth, LLC | 248,070 | $10,987,000 | 1.47% |